Special Opportunities
Distressed assets, restructurings and complex transactions, supported by experience in asset recovery, corporate restructuring and structured investment situations.
Read more
Hong Kong Licensed Asset Manager · CE No. BSV377
Institutional Investment with Focus and Discipline
A Hong Kong licensed asset manager, wholly owned by Peking University Resources (Holdings) Company Limited, providing investment-management solutions to professional investors, family offices and institutional partners.
Our focused strategies cover special opportunities, public and systematic markets, and selected private equity investments.
00618.HK
Wholly owned by a Main Board listed company
Type 4 & Type 9
SFC regulated activities under CE No. BSV377
Two Responsible Officers
Licensed supervision of all investment activity
Investment Pillars
Three focused pillars.
Public and Systematic Markets
Listed equities, secondary-market opportunities, futures, commodities, and selected IPO, anchor and cornerstone participation.
Read morePrivate Equity
Selected private equity opportunities, primarily in healthcare, longevity and wellness, together with AI, semiconductor and related technology businesses.
Read moreInvestment Capability
Experienced judgement, supported by quantitative research.
Our investment process combines experienced judgement, quantitative research, proprietary algorithm development and disciplined oversight. An internal ALGO strategy team supports research, backtesting, validation and controlled implementation as part of the investment decision-making process.
Final investment decisions remain subject to human review, Responsible Officer supervision and Investment Committee approval.
Our ApproachHealthcare Private Equity Advantage
Sector expertise across healthy ageing and medical technology.
Advisory Board members include Professor Richard Siow, Dr. GSK Velu, Dr. Vasanthan Metupalle and Dr. Henry Loh, covering healthy ageing, medical technology, diagnostics, digital health, clinical operations and healthcare investment.
The Advisory Board is non-statutory and consultative, with no executive or voting authority. Subject to governance arrangements, its sector expertise may support selected healthcare opportunity assessments; final investment decisions remain with the licensed Manager.
Investment decisions are subject to Responsible Officer supervision, Investment Committee review, documented risk limits, fund operations, compliance monitoring and control governance.